136 related articles for article (PubMed ID: 20358420)
1. Blocking EGFR in the liver improves the tumor-to-liver uptake ratio of radiolabeled EGF.
Kareem H; Sandström K; Elia R; Gedda L; Anniko M; Lundqvist H; Nestor M
Tumour Biol; 2010 Apr; 31(2):79-87. PubMed ID: 20358420
[TBL] [Abstract][Full Text] [Related]
2. Improved tumor-to-organ ratios of a novel 67Ga-human epidermal growth factor radionuclide conjugate with preadministered antiepidermal growth factor receptor affibody molecules.
Sandström K; Haylock AK; Velikyan I; Spiegelberg D; Kareem H; Tolmachev V; Lundqvist H; Nestor M
Cancer Biother Radiopharm; 2011 Oct; 26(5):593-601. PubMed ID: 21834651
[TBL] [Abstract][Full Text] [Related]
3. Imaging of human tumor xenografts with an indium-111-labeled anti-epidermal growth factor receptor monoclonal antibody.
Goldenberg A; Masui H; Divgi C; Kamrath H; Pentlow K; Mendelsohn J
J Natl Cancer Inst; 1989 Nov; 81(21):1616-25. PubMed ID: 2795690
[TBL] [Abstract][Full Text] [Related]
4. 177Lu-DO3A-HSA-Z EGFR:1907: characterization as a potential radiopharmaceutical for radionuclide therapy of EGFR-expressing head and neck carcinomas.
Hoppmann S; Qi S; Miao Z; Liu H; Jiang H; Cutler CS; Bao A; Cheng Z
J Biol Inorg Chem; 2012 Jun; 17(5):709-18. PubMed ID: 22418921
[TBL] [Abstract][Full Text] [Related]
5. Conjugation with (111)In-DTPA-poly(ethylene glycol) improves imaging of anti-EGF receptor antibody C225.
Wen X; Wu QP; Ke S; Ellis L; Charnsangavej C; Delpassand AS; Wallace S; Li C
J Nucl Med; 2001 Oct; 42(10):1530-7. PubMed ID: 11585869
[TBL] [Abstract][Full Text] [Related]
6. Dual-Receptor-Targeted Radioimmunotherapy of Human Breast Cancer Xenografts in Athymic Mice Coexpressing HER2 and EGFR Using 177Lu- or 111In-Labeled Bispecific Radioimmunoconjugates.
Razumienko EJ; Chen JC; Cai Z; Chan C; Reilly RM
J Nucl Med; 2016 Mar; 57(3):444-52. PubMed ID: 26429962
[TBL] [Abstract][Full Text] [Related]
7. 111In-cetuximab-F(ab')2 SPECT imaging for quantification of accessible epidermal growth factor receptors (EGFR) in HNSCC xenografts.
van Dijk LK; Hoeben BA; Stegeman H; Kaanders JH; Franssen GM; Boerman OC; Bussink J
Radiother Oncol; 2013 Sep; 108(3):484-8. PubMed ID: 23932156
[TBL] [Abstract][Full Text] [Related]
8. Gefitinib enhances radiotherapeutic effects of
Xia L; Peng H; Zhiqiang L; Xiaoli Z
Nucl Med Biol; 2017 May; 48():63-68. PubMed ID: 28254656
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of systemically administered radiolabeled epidermal growth factor as a brain tumor targeting agent.
Yang W; Barth RF; Leveille R; Adams DM; Ciesielski M; Fenstermaker RA; Capala J
J Neurooncol; 2001 Oct; 55(1):19-28. PubMed ID: 11804279
[TBL] [Abstract][Full Text] [Related]
10. PET imaging of EGF receptors using [18F]FBEM-EGF in a head and neck squamous cell carcinoma model.
Li W; Niu G; Lang L; Guo N; Ma Y; Kiesewetter DO; Backer JM; Shen B; Chen X
Eur J Nucl Med Mol Imaging; 2012 Feb; 39(2):300-8. PubMed ID: 22109665
[TBL] [Abstract][Full Text] [Related]
11. In vivo evaluation of epidermal growth factor (EGF) receptor density on human tumor xenografts using radiolabeled EGF and anti-(EGF receptor) mAb 425.
Senekowitsch-Schmidtke R; Steiner K; Haunschild J; Möllenstädt S; Truckenbrodt R
Cancer Immunol Immunother; 1996 Feb; 42(2):108-14. PubMed ID: 8620519
[TBL] [Abstract][Full Text] [Related]
12. Imaging of EGFR expression in murine xenografts using site-specifically labelled anti-EGFR 111In-DOTA-Z EGFR:2377 Affibody molecule: aspect of the injected tracer amount.
Tolmachev V; Rosik D; Wållberg H; Sjöberg A; Sandström M; Hansson M; Wennborg A; Orlova A
Eur J Nucl Med Mol Imaging; 2010 Mar; 37(3):613-22. PubMed ID: 19838701
[TBL] [Abstract][Full Text] [Related]
13.
Kwon LY; Scollard DA; Reilly RM
Mol Pharm; 2017 Feb; 14(2):492-501. PubMed ID: 28049295
[TBL] [Abstract][Full Text] [Related]
14. Affibody molecules for epidermal growth factor receptor targeting in vivo: aspects of dimerization and labeling chemistry.
Tolmachev V; Friedman M; Sandström M; Eriksson TL; Rosik D; Hodik M; Ståhl S; Frejd FY; Orlova A
J Nucl Med; 2009 Feb; 50(2):274-83. PubMed ID: 19164241
[TBL] [Abstract][Full Text] [Related]
15. Convection enhanced delivery of boronated EGF as a molecular targeting agent for neutron capture therapy of brain tumors.
Yang W; Barth RF; Wu G; Huo T; Tjarks W; Ciesielski M; Fenstermaker RA; Ross BD; Wikstrand CJ; Riley KJ; Binns PJ
J Neurooncol; 2009 Dec; 95(3):355-365. PubMed ID: 19588228
[TBL] [Abstract][Full Text] [Related]
16. Targeted killing of cancer cells in vivo and in vitro with EGF-directed carbon nanotube-based drug delivery.
Bhirde AA; Patel V; Gavard J; Zhang G; Sousa AA; Masedunskas A; Leapman RD; Weigert R; Gutkind JS; Rusling JF
ACS Nano; 2009 Feb; 3(2):307-16. PubMed ID: 19236065
[TBL] [Abstract][Full Text] [Related]
17. Cellular studies of binding, internalization and retention of a radiolabeled EGFR-binding affibody molecule.
Nordberg E; Friedman M; Göstring L; Adams GP; Brismar H; Nilsson FY; Ståhl S; Glimelius B; Carlsson J
Nucl Med Biol; 2007 Aug; 34(6):609-18. PubMed ID: 17707800
[TBL] [Abstract][Full Text] [Related]
18. Near-infrared optical imaging of epidermal growth factor receptor in breast cancer xenografts.
Ke S; Wen X; Gurfinkel M; Charnsangavej C; Wallace S; Sevick-Muraca EM; Li C
Cancer Res; 2003 Nov; 63(22):7870-5. PubMed ID: 14633715
[TBL] [Abstract][Full Text] [Related]
19. Antisense imaging of epidermal growth factor-induced p21(WAF-1/CIP-1) gene expression in MDA-MB-468 human breast cancer xenografts.
Wang J; Chen P; Mrkobrada M; Hu M; Vallis KA; Reilly RM
Eur J Nucl Med Mol Imaging; 2003 Sep; 30(9):1273-80. PubMed ID: 12640557
[TBL] [Abstract][Full Text] [Related]
20. Epidermal growth factor radiopharmaceuticals: 111In chelation, conjugation to a blood-brain barrier delivery vector via a biotin-polyethylene linker, pharmacokinetics, and in vivo imaging of experimental brain tumors.
Kurihara A; Deguchi Y; Pardridge WM
Bioconjug Chem; 1999; 10(3):502-11. PubMed ID: 10346884
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
